PATENT CLAIM ANALYSIS

Application Number: 15990711
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["546", "113000"]

Abstract:
The present invention relates to a process for the preparation substantially pure propane-1-sulfonicacid-{3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide or Vemurafenib of Formula (I). The present invention further relates to a process for the preparation substantially pure propane-1-sulfonic acid-{3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3 -b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide trifluoro methane sulfonic acid salt or Vemurafenib triflate of Formula (VII)

Claim (Index 3):
A process for the preparation of substantially pure Vemurafenib according to  claim 1 , wherein halogenating agent used in step a) is in the ratio between 2-10 v/w times with respect to 2,6-difluoro-3-(((propan-1-yl)sulphonyl)amino)benzoic acid (II).

Metadata:
- Claim Count in Document: 6.0
- Percentile: 93.0
- Lexical Diversity: 1.82222
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15527721', '13816376', '14373163', '16068575', '15366229']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7514818074359071
- 35 USC 102 Novelty (BERT): 0.5301288387286222
- Combined Prediction Score: 0.7293465105651786
- Mean Citation Score: 257.726786
- Max Citation Score: 326.7036700000001
- Similarity Product: 212.3330753366436

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test